Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Research & Clinical Trials Retatrutide for Obesity: Phase 2 Trial The study concluded that Retatrutide, an investigational medication developed by Eli Lilly, was highly effective in promoting significant weight loss in adults with obesity who did not have type 2 diabetes
Semaglutide, administered once weekly at dosages ranging from 0.5 to 1 mg, showed superior efficacy compared to Dulaglutide, dosed once weekly from 0.75 to 1.5 mg, reducing both HbA1c and FBS levels
H2 Lipo 360 is a circumferential liposuction technique that targets the entire midsection in one session, including the upper abdomen, lower abdomen, waist, flanks, and back
Preventative health and wellness are at the heart of everything we do
Rotating injection sites helps prevent lipodystrophy, where repeated injections in the same area cause changes in the fat tissue
